Secor Capital Advisors’s Avanos Medical AVNS Stock Holding History

Secor Capital Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-15,405	Closed	-$1.05M	–	476
2018 Q3	$1.05M	Buy	+15,405	New	+$991K	0.11%	245
2016 Q3	–	Sell	-44,381	Closed	-$1.44M	–	510
2016 Q2	$1.44M	Buy	44,381 +9,278	+26%	+$284K	0.18%	179
2016 Q1	$1.01M	Buy	+35,103	New	+$935K	0.14%	158
2015 Q4	–	Sell	-7,564	Closed	-$215K	–	533
2015 Q3	$215K	Sell	7,564 -28,228	-79%	-$985K	0.07%	432
2015 Q2	$1.45M	Buy	35,792 +29,490	+468%	+$1.32M	0.52%	41
2015 Q1	$310K	Buy	+6,302	New	+$292K	0.12%	301

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Secor Capital Advisors's AVNS Position: Q4 2018 in Review

Secor Capital Advisors sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 15,405 shares — an estimated $1.05M sold.

Secor Capital Advisors first reported a position in AVNS in Q1 2015 and held it in 6 quarters. The position peaked at $1.45M in Q2 2015. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

Secor Capital Advisors reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
Secor Capital Advisors sold 15,405 Avanos Medical shares in Q4 2018, an estimated $1.05M.
Secor Capital Advisors first reported a position in Avanos Medical in Q1 2015 and held it in 6 quarters.
Secor Capital Advisors's Avanos Medical position peaked at $1.45M in Q2 2015.
350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Secor Capital Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.